Adjunctive Nuvigil Possibly Effective for Bipolar Depression Carlat Reports

Adjunctive Nuvigil Possibly Effective for Bipolar Depression

The Carlat Psychiatry Report, Volume 9, Number 1, January 2011
https://www.thecarlatreport.com/newsletter-issue/tcprv9n1/

From The Carlat Psychiatry Report, January 2011, Bipolar Disorder

Issue Links: Learning Objectives | Editorial Information

Topics: Bipolar Disorder | Depressive Disorder

The treatment of bipolar depression remains challenging. Only two medications are FDA approved for the condition—quetiapine (Seroquel) and olanzapine (Zyprexa)/fluoxetine (Prozac) combination—both of which cause weight gain and sedation, among other side effects.

You can't view details of this content, please login or buy subscription here

Section editor, Glen Spielmans, PhD

Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.